APAC Colorectal Cancer Market to Grow at 7.9% CAGR through 2023, Forecasts GBI Research in Its New Discounted Report Available at MarketPublishers.com

17 Aug 2017 • by Natalie Aster

LONDON – The number of colorectal cancer (CRC) incidence in the APAC region rises every year with the escalating number of elderly population and enhancing shift to westernized lifestyles.

The poor prognosis, especially for patients at advanced stages of the disease, has resulted in a pressing need for improved therapeutic options. Therefore, today the CRC market is gradually shifting to a focus on a complex treatment landscape that is based on the presence of different molecular aberrations.

At present, there is a wide choice of marketed products for CRC treatment including angiogenesis inhibitors, EGFR-targeted therapies, new chemotherapies and multiple kinase inhibitors. Still, considerbale unmet need remains for treatment options for BRAF-mutant CRC patients; a therapy targeting mutant BRAF, encorafenib plus binimetinib, is currently being developed in the pipeline.

As of 2016, the APAC CRC market was evaluated at around USD 4.7 billion. This regional CRC market is set to increase at a 7.9% CAGR through 2023 to reach USD 7.9 billion. Many late-stage pipeline therapies with a strong clinical record are expected to enter the market in the years ahead. Japan is predicted to make the largest contribution to the APAC CRC market growth through 2023 owing to introduction of new therapies.

New discounted report “Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market” elaborated by GBI Research is a trustworthy source of unique data on the CRC market landscape and dynamics in the APAC region. It presents a comprehensive profile of the disease, describes the current clinical and commercial landscape, and gives a profound analysis of the CRC pipeline. This topical report highlights the APC CRC market current scenario, discusses prevailing development trends, identifies the major market growth limiting and driving factors, outlines the emerging growth opportunities and barriers, touches upon competitive environment and highlights the main regulative policies. In addition, this report gives forecasts through 2023.

Note that this in-demand report is currently available at a lucrative discount! Further details on the discount offer are available at this page.

For a full collection of the publisher’s research studies follow to GBI Research page at MarketPublishers.com.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com